Key player · Company profile
Sanofi
Named as a key player in 495 of our reports, across 33 regions and countries.
Named as a key player in 495 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 15
Brazil 15
Canada 15
China 15
Ecuador 15
Egypt 15
France 15
Germany 15
Hong Kong 15
India 15
Italy 15
Japan 15
Kenya 15
Malaysia 15
Mexico 15
New Zealand 15
Philippines 15
Russia 15
Saudi Arabia 15
Singapore 15
South Africa 15
Spain 15
Thailand 15
UAE 15
UK 15
US 15| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Gastrointestinal Drugs | Pharmaceuticals | $54 Bn | 4.6% |
| Over The Counter (OTC) Analgesics | OTC & Nutraceuticals | $22 Bn | 3.4% |
| Anti-Depressants Drugs | Pharmaceuticals | $18 Bn | 2.7% |
| Insulin Delivery Devices | Medical Devices | $15.9 Bn | 6.5% |
| Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs | OTC & Nutraceuticals | $14.5 Bn | 4.1% |
| Atopic Dermatitis Drugs | Pharmaceuticals | $11.2 Bn | 12.2% |
| Over The Counter (OTC) Gastrointestinal Drugs | OTC & Nutraceuticals | $5.6 Bn | 3.9% |
| Vitamin B12(Cobalamin) | OTC & Nutraceuticals | $300 Mn | 5.5% |
| Alexipharmic Drugs | Pharmaceuticals | – | – |
| Alopecia areata | Healthcare Services | – | – |
| Anemia Drugs | Pharmaceuticals | – | – |
| Anti-Nerve Growth Factor | Pharmaceuticals | – | – |
| Anticoagulants | Pharmaceuticals | – | – |
| Antithrombotic Drugs | Pharmaceuticals | – | – |
| Atherosclerosis Drugs | Pharmaceuticals | – | – |
Named as key players in the same markets as Sanofi (number of shared markets).
AstraZeneca8 shared markets
Bristol-Myers Squibb Company7 shared markets
Johnson & Johnson7 shared markets
Pfizer Inc.7 shared markets
Bayer AG5 shared markets
Merck & Co., Inc.5 shared markets
Novartis AG5 shared markets
AbbVie Inc.4 shared markets